Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

✍ Scribed by Michael Millward, Timothy Price, Amanda Townsend, Christopher Sweeney, Andrew Spencer, Shawgi Sukumaran, Angie Longenecker, Lonnie Lee, Ana Lay, Girish Sharma, Robert M. Gemmill, Harry A. Drabkin, G. Kenneth Lloyd, Saskia T. C. Neuteboom, David J. McConkey, et al

• Book ID: 118299064
• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 688 KB
• Volume: 30
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-011-9766-6